Latest News

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, highlighting concerns about global economic recovery. In such a climate, identifying undervalued stocks—those trading below their intrinsic value—can present opportunities for investors seeking potential gains despite broader market uncertainties.

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The UK market has recently faced challenges, with the FTSE 100 index closing lower amid weak trade data from China, highlighting concerns about global economic recovery. Despite these broader market uncertainties, investors often seek opportunities in less conventional areas such as penny stocks. While the term 'penny stock' might seem outdated, it continues to represent potential in smaller or newer companies that possess strong financial foundations. Here, we explore three UK penny stocks...

As the FTSE 100 faces pressure from weak trade data out of China, impacting companies with strong ties to the Chinese economy, UK investors are increasingly seeking stability in dividend stocks. In such uncertain market conditions, a good dividend stock is often characterized by consistent payouts and a resilient business model that can weather global economic fluctuations.

Key Insights The considerable ownership by state or government in Canara Bank indicates that they collectively have a...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Key Insights Mandatum Oyj's significant individual investors ownership suggests that the key decisions are influenced...

Hayward Holdings recently reported quarterly results showing 7.4% year-on-year revenue growth, beating analyst and organic growth estimates and topping EBITDA forecasts. The company also delivered the largest full-year guidance increase among its peers, suggesting its pool equipment and automation business has stronger momentum than previously assumed. Now we’ll explore how this guidance upgrade and earnings beat could influence Hayward’s investment narrative and future earnings...

DSC Meridian Capital’s fresh stake in Elme Communities (ELME) comes shortly after Elme’s roughly $1.6 billion sale of 19 multifamily properties, a move that is sharpening investor focus on underlying asset value. See our latest analysis for Elme Communities. With the portfolio sale reframing Elme as a leaner multifamily REIT, the stock’s roughly 15 percent year to date share price return and near 20 percent one year total shareholder return suggest that momentum is quietly rebuilding as...

Customers Bancorp (CUBI) has been quietly rewarding patient shareholders, with the stock climbing about 20% over the past month and more than 60% this year. This performance is prompting a closer look at what is driving the move. See our latest analysis for Customers Bancorp. At around $77.91 per share, Customers Bancorp’s strong recent 1 month share price return sits on top of an already impressive multi year total shareholder return record. This may indicate that momentum is still building...

Earlier this week, JPMorgan upgraded Shake Shack from Underweight to Neutral, citing the chain’s evolution into a free cash flow positive business and a stronger financial profile. The shift to generating free cash flow marks an important milestone for Shake Shack, potentially giving the company more flexibility to fund its ambitious expansion plans. Next, we’ll explore how this newfound free cash flow strength could influence Shake Shack’s longer-term investment narrative and growth...

MBX Biosciences (MBX) slipped onto more traders radars after Goldman Sachs launched coverage with a bearish stance, questioning how much value the company can prove beyond its lead hormone therapy canvuparatide. See our latest analysis for MBX Biosciences. Despite Goldman’s cautious view, MBX’s recent 1 day share price return of 3.5 percent to 28.67 dollars comes after a powerful 90 day share price return of 186.7 percent and 1 year total shareholder return of 40.8 percent, suggesting...

Southern Cross Gold Consolidated (TSX:SXGC) has quietly turned into one of the stronger movers on the TSX, with the stock up about 6% today and roughly 25% over the past month. See our latest analysis for Southern Cross Gold Consolidated. With the share price now at CA$8.84 and a year to date share price return of about 175%, the recent 30 day share price return of roughly 25% suggests momentum is still building as investors warm to its exploration story and risk profile. If you are looking...

Repligen (RGEN) just widened its bioprocessing toolkit with three new chromatography resins aimed at gene therapy workflows, a move that quietly matters for both long term growth expectations and the stock’s quality story. See our latest analysis for Repligen. Repligen’s new resin launches land after a bumpy stretch, with a strong 90 day share price return of 28.96 percent off a softer year to date base. However, the 1 year total shareholder return of 7.63 percent still masks a weaker multi...

Beam Therapeutics (BEAM) just updated investors on new safety and efficacy results from its BEACON Phase 1/2 trial in sickle cell disease, and the stock is reacting to what this means for future commercialization. See our latest analysis for Beam Therapeutics. The latest BEACON update lands after a choppy year, with a 24.74% 1 month share price return but a 1 year total shareholder return of negative 9.79%. This suggests that near term momentum is improving even as longer term holders remain...

Kennedy Wilson (KW) is drawing fresh attention after providing a $306 million senior non recourse construction loan for the Harborside 8 multifamily tower in Jersey City, a sizable bet on high demand rental housing. See our latest analysis for Kennedy-Wilson Holdings. That push into high demand multifamily lending comes as Kennedy-Wilson Holdings’ share price has quietly delivered a 14.27% 90 day share price return, while its 1 year total shareholder return of 3.86% masks a still weak 3 year...

MPLX LP recently expanded its midstream footprint with the acquisition of Northwind Midstream, completed a US$1.00 billion asset sale to Harvest Midstream, and earlier reported Q3 2025 earnings that exceeded analyst expectations. The appointment of Maria A. Khoury to the MPLX GP LLC board, coinciding with her move to Marathon Petroleum as CFO in January 2026, underscores tighter financial alignment between the partnership and its parent at a time of active portfolio reshaping. We’ll now...

In the third quarter, Dallas-based Permian Investment Partners lifted its holding in TIC Solutions, Inc. by nearly 4.9 million shares, making the company about 21.9% of its reportable assets and its largest portfolio position. This sizable institutional commitment highlights confidence in TIC Solutions' recurring, compliance-driven business model and its improved cost synergy targets despite earlier volatility. We'll now examine how Permian's enlarged TIC Solutions stake, signaling...

Avadel Pharmaceuticals (AVDL) has quietly turned into one of those under the radar movers, with the stock nearly doubling this year even after a recent pullback over the past month. See our latest analysis for Avadel Pharmaceuticals. With the share price now at $21.42, Avadel’s roughly 32% 3 month share price return and 107.76% 1 year total shareholder return suggest momentum is still building as investors reassess its growth runway and risk profile. If Avadel’s run has you rethinking your...

If you have been wondering whether Equinix at around $744 a share is a bargain or a value trap, you are not alone. This article is going to walk through what the numbers are really saying. The stock is down about 0.8% over the last week and 2.7% over the last month, adding to a tougher stretch with returns of roughly 21.2% lower year to date and 17.9% lower over the past year, even though it is still up 20.4% over three years and 16.1% over five years. That mixed performance comes as...

Borr Drilling (NYSE:BORR) just made a big move, agreeing to buy five premium jack up rigs from Noble and supporting the deal with fresh equity, new debt, and a push toward dual listing. See our latest analysis for Borr Drilling. The acquisition news lands after a volatile spell, with a 30 day share price return of 23.23 percent and a five year total shareholder return of 121.15 percent. This suggests long term momentum remains broadly constructive despite bumps along the way. If this kind of...

In recent months, multiple law firms have filed securities class action lawsuits against Stride, Inc., alleging inflated enrollment figures using “ghost students,” compliance failures, and suppression of whistleblowers between October 22, 2024 and October 28, 2025. These coordinated legal actions focus sharply on whether Stride’s reported enrollment metrics and operational practices accurately reflected the health and integrity of its underlying business. Next, we’ll examine how these fraud...

Hygeia Healthcare Holdings (SEHK:6078) has kicked off a sizeable share buyback after shareholders approved a mandate to repurchase up to 10% of its issued share capital, signaling a clearer commitment to shareholder returns. See our latest analysis for Hygeia Healthcare Holdings. The buyback comes after a weak stretch in the market, with the share price down sharply on a 3 year total shareholder return basis. However, the recent 7 day share price return of 9.64% suggests sentiment may be...